Form 4: Vor Biopharma Inc. Executive Chakraborty Sells Shares to Cover Tax Obligations

Chief Scientific Officer Tirtha Chakraborty of Vor Biopharma Inc. sold 875 shares of common stock on November 6, 2024, to cover tax withholding obligations related to the settlement of restricted stock units.

Summary

• On November 6, 2024, Tirtha Chakraborty, the Chief Scientific Officer of Vor Biopharma Inc., disposed of 875 shares of common stock.
• The transaction was executed to satisfy tax withholding obligations associated with the settlement of restricted stock units.
• The shares were sold at a price of $0.86 per share.
• Following the transaction, Chakraborty directly owns 169,935 shares of Vor Biopharma Inc.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (selling shares to cover taxes) and doesn't indicate any significant positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of the US stock market and are required by the SEC to provide transparency into the transactions of company insiders.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on stakeholders as it is a routine sale of shares by an executive to cover tax obligations.

Key Dates